Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
IT
|
Yvonne Genovese
EVP, Global Product Management |
SELL
Open market or private sale
|
Direct | 443 Reduced 18.44% |
$214,243
$483.62 p/Share
|
Aug 26
2024 |
KERN
|
Heather Cox
Director |
BUY
Grant, award, or other acquisition
|
Direct | 14,035 Added 25.0% |
-
|
Aug 26
2024 |
KERN
|
Steven D. Gutterman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 14,035 Added 33.33% |
-
|
Aug 26
2024 |
DFH
|
Patrick O. Zalupski
President and CEO |
SELL
Open market or private sale
|
Direct | 54,665 Reduced 4.92% |
$1,841,117
$33.68 p/Share
|
Aug 26
2024 |
GSHD
|
Mark Evan Jones
Executive Chairman |
SELL
Open market or private sale
|
Direct | 8,977 Reduced 18.54% |
$739,076
$82.33 p/Share
|
Aug 26
2024 |
GSHD
|
Mark Evan Jones
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 8,977 Added 15.64% |
$89,770
$10.0 p/Share
|
Aug 26
2024 |
CBT
|
Jeff Ji Zhu
Executive Vice President |
SELL
Open market or private sale
|
Direct | 1,201 Reduced 1.24% |
$127,534
$106.19 p/Share
|
Aug 26
2024 |
ACLX
|
Christopher Heery
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 21,684 Reduced 70.03% |
$1,538,913
$70.97 p/Share
|
Aug 26
2024 |
ACLX
|
Christopher Heery
CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 21,684 Added 41.19% |
$325,260
$15.0 p/Share
|
Aug 26
2024 |
PHR
|
Allison C Hoffman
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 14,110 Reduced 10.44% |
$367,283
$26.03 p/Share
|
Aug 26
2024 |
ODFL
|
David S Congdon
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 29,975 Reduced 0.0% |
$6,063,942
$202.3 p/Share
|
Aug 26
2024 |
BRZE
|
Isabelle Winkles
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 4.42% |
$451,500
$45.15 p/Share
|
Aug 26
2024 |
DDS
|
Brant Musgrave
CORPORATE VP STORES |
BUY
Grant, award, or other acquisition
|
Direct | 12 Added 0.34% |
$4,251
$354.25 p/Share
|
Aug 26
2024 |
DDS
|
Tom W Bolin
VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 17 Added 1.26% |
$6,022
$354.25 p/Share
|
Aug 26
2024 |
GIC
|
Claudia Hughes
SVP & Chief Sales Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 473 Reduced 2.25% |
$14,833
$31.36 p/Share
|
Aug 26
2024 |
DDS
|
Mike Dillard
EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 18 Added 0.0% |
$6,376
$354.25 p/Share
|
Aug 26
2024 |
TLIS
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect | 13,167 Added 0.0% |
$51,351
$3.9 p/Share
|
Aug 26
2024 |
DDS
|
Deborah Dillard
SENIOR VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 16 Added 0.01% |
$5,668
$354.25 p/Share
|
Aug 26
2024 |
DDS
|
James D Stockman
VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 18 Added 0.05% |
$6,376
$354.25 p/Share
|
Aug 26
2024 |
DDS
|
Mike Litchford
VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 13 Added 0.43% |
$4,605
$354.25 p/Share
|
Aug 26
2024 |
DDS
|
William T. Dillard Iii
SENIOR VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 17 Added 0.05% |
$6,022
$354.25 p/Share
|
Aug 26
2024 |
DDS
|
Phillip R. Watts
SENIOR VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 15 Added 0.16% |
$5,313
$354.25 p/Share
|
Aug 26
2024 |
DDS
|
Dean L. Worley
VP/GENERAL COUNSEL & SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct | 13 Added 0.2% |
$4,605
$354.25 p/Share
|
Aug 26
2024 |
BRZE
|
Myles Kleeger
Pres & CCO |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 20.0% |
$2,291,500
$45.83 p/Share
|
Aug 26
2024 |
BRZE
|
Myles Kleeger
Pres & CCO |
BUY
Conversion of derivative security
|
Direct | 50,000 Added 16.67% |
-
|
Aug 26
2024 |
RCII
|
Transient C Taylor
EVP, CHRO |
SELL
Open market or private sale
|
Direct | 15,127 Reduced 50.8% |
$514,318
$34.0 p/Share
|
Aug 26
2024 |
DDS
|
Annemarie Jazic
VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 10 Added 0.03% |
$3,542
$354.25 p/Share
|
Aug 26
2024 |
DDS
|
Denise Alexandra Lucie
VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 11 Added 0.03% |
$3,896
$354.25 p/Share
|
Aug 26
2024 |
DDS
|
Chris B. Johnson
SENIOR VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 15 Added 0.16% |
$5,313
$354.25 p/Share
|
Aug 26
2024 |
GBDC
|
Lawrence E Golub
Chairman |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 0.0% |
$300,200
$15.01 p/Share
|
Aug 26
2024 |
FIVN
|
Daniel P. Burkland
Pres. & Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 2,605 Reduced 1.93% |
$87,033
$33.41 p/Share
|
Aug 26
2024 |
DDS
|
Drue Matheny
EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 18 Added 0.0% |
$6,376
$354.25 p/Share
|
Aug 26
2024 |
DDS
|
William T Dillard Ii
CEO, CHAIRMAN OF BOARD |
BUY
Grant, award, or other acquisition
|
Direct | 25 Added 0.0% |
$8,856
$354.25 p/Share
|
Aug 26
2024 |
DDS
|
Alex Dillard
PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 25 Added 0.0% |
$8,856
$354.25 p/Share
|
Aug 26
2024 |
RKT
|
Matthew Rizik
Director |
BUY
Grant, award, or other acquisition
|
Direct | 192,492 Added 17.62% |
-
|
Aug 26
2024 |
PAYO
|
John Caplan
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 63,813 Reduced 1.28% |
$448,605
$7.03 p/Share
|
Aug 26
2024 |
PGNY
|
Michael E Sturmer
PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct | 7,977 Reduced 2.2% |
$173,898
$21.8 p/Share
|
Aug 26
2024 |
RKT
|
Heather M. Lovier
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 60,153 Added 9.75% |
-
|
Aug 26
2024 |
PH
|
Berend Bracht
VP & Pres.- Motion Sys. Grp. |
SELL
Open market or private sale
|
Direct | 850 Reduced 20.24% |
$503,981
$592.92 p/Share
|
Aug 26
2024 |
CAVA
|
James D White
Director |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 23.78% |
$190,770
$127.18 p/Share
|
Aug 26
2024 |
CAVA
|
Theodoros Xenohristos
Director |
SELL
Open market or private sale
|
Direct | 98,490 Reduced 18.82% |
$12,390,042
$125.8 p/Share
|
Aug 26
2024 |
CAVA
|
Theodoros Xenohristos
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 98,490 Added 15.84% |
$126,067
$1.28 p/Share
|
Aug 26
2024 |
GBDC
|
David Golub
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 0.0% |
$300,200
$15.01 p/Share
|
Aug 26
2024 |
CAVA
|
David Bosserman
Director |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$634,850
$126.97 p/Share
|
Aug 26
2024 |
CAVA
|
Tricia K. Tolivar
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.68% |
$628,200
$125.64 p/Share
|
Aug 26
2024 |
CAVA
|
Brett Schulman
CEO and President |
SELL
Open market or private sale
|
Direct | 201,504 Reduced 22.29% |
$25,329,052
$125.7 p/Share
|
Aug 26
2024 |
SBTX
|
Peter A. Thompson
Director |
SELL
Open market or private sale
|
Indirect | 83,695 Reduced 0.0% |
$1,088,035
$13.0 p/Share
|
Aug 26
2024 |
CAVA
|
Artal International S.C.A. |
SELL
Open market or private sale
|
Direct | 6,000,000 Reduced 25.52% |
$698,160,000
$116.36 p/Share
|
Aug 26
2024 |
MXCT
|
John Joseph Johnston |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 2.07% |
$12,840
$4.28 p/Share
|
Aug 26
2024 |
MXCT
|
John Joseph Johnston |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 2.03% |
$8,790
$2.93 p/Share
|
Aug 26
2024 |